Use access key #2 to skip to page content.
$0.24 0.05 (20.83%)
10/6/2008 4:00 PM

Panacos Pharmaceuticals, Inc. (PANC)

CAPS Rating:
****

A development stage biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat HIV and other major human viral diseases.

View All Commentary (PANC)

Recs

0

Avatar utosweet (66.93) Submitted: 12/07/07 9:53 AM : Outperform Start Price: $2.05 PANC Score: -57.60

phase2 trial for hiv very good.

Report this Post Replies: 0 | Reply

Featured Broker Partners